Table of Content

1 Prilide Antihypertensive Drugs Market Overview
1.1 Product Overview and Scope of Prilide Antihypertensive Drugs
1.2 Prilide Antihypertensive Drugs Segment by Type
1.2.1 Global Prilide Antihypertensive Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Captopril
1.2.3 Enalapril
1.2.4 Lisinopril
1.2.5 Fosinopril
1.2.6 Others
1.3 Prilide Antihypertensive Drugs Segment by Application
1.3.1 Global Prilide Antihypertensive Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Prilide Antihypertensive Drugs Market Size Estimates and Forecasts
1.4.1 Global Prilide Antihypertensive Drugs Revenue 2024-2034
1.4.2 Global Prilide Antihypertensive Drugs Sales 2024-2034
1.4.3 Global Prilide Antihypertensive Drugs Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Prilide Antihypertensive Drugs Market Competition by Manufacturers
2.1 Global Prilide Antihypertensive Drugs Sales Market Share by Manufacturers (2024-2024)
2.2 Global Prilide Antihypertensive Drugs Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Prilide Antihypertensive Drugs Average Price by Manufacturers (2024-2024)
2.4 Global Prilide Antihypertensive Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Prilide Antihypertensive Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prilide Antihypertensive Drugs, Product Type & Application
2.7 Prilide Antihypertensive Drugs Market Competitive Situation and Trends
2.7.1 Prilide Antihypertensive Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prilide Antihypertensive Drugs Players Market Share by Revenue
2.7.3 Global Prilide Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prilide Antihypertensive Drugs Retrospective Market Scenario by Region
3.1 Global Prilide Antihypertensive Drugs Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Prilide Antihypertensive Drugs Global Prilide Antihypertensive Drugs Sales by Region: 2024-2034
3.2.1 Global Prilide Antihypertensive Drugs Sales by Region: 2024-2024
3.2.2 Global Prilide Antihypertensive Drugs Sales by Region: 2024-2034
3.3 Global Prilide Antihypertensive Drugs Global Prilide Antihypertensive Drugs Revenue by Region: 2024-2034
3.3.1 Global Prilide Antihypertensive Drugs Revenue by Region: 2024-2024
3.3.2 Global Prilide Antihypertensive Drugs Revenue by Region: 2024-2034
3.4 North America Prilide Antihypertensive Drugs Market Facts & Figures by Country
3.4.1 North America Prilide Antihypertensive Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Prilide Antihypertensive Drugs Sales by Country (2024-2034)
3.4.3 North America Prilide Antihypertensive Drugs Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prilide Antihypertensive Drugs Market Facts & Figures by Country
3.5.1 Europe Prilide Antihypertensive Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Prilide Antihypertensive Drugs Sales by Country (2024-2034)
3.5.3 Europe Prilide Antihypertensive Drugs Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prilide Antihypertensive Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Prilide Antihypertensive Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Prilide Antihypertensive Drugs Sales by Country (2024-2034)
3.6.3 Asia Pacific Prilide Antihypertensive Drugs Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prilide Antihypertensive Drugs Market Facts & Figures by Country
3.7.1 Latin America Prilide Antihypertensive Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Prilide Antihypertensive Drugs Sales by Country (2024-2034)
3.7.3 Latin America Prilide Antihypertensive Drugs Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prilide Antihypertensive Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Prilide Antihypertensive Drugs Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Prilide Antihypertensive Drugs Sales by Country (2024-2034)
3.8.3 Middle East and Africa Prilide Antihypertensive Drugs Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prilide Antihypertensive Drugs Sales by Type (2024-2034)
4.1.1 Global Prilide Antihypertensive Drugs Sales by Type (2024-2024)
4.1.2 Global Prilide Antihypertensive Drugs Sales by Type (2024-2034)
4.1.3 Global Prilide Antihypertensive Drugs Sales Market Share by Type (2024-2034)
4.2 Global Prilide Antihypertensive Drugs Revenue by Type (2024-2034)
4.2.1 Global Prilide Antihypertensive Drugs Revenue by Type (2024-2024)
4.2.2 Global Prilide Antihypertensive Drugs Revenue by Type (2024-2034)
4.2.3 Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2024-2034)
4.3 Global Prilide Antihypertensive Drugs Price by Type (2024-2034)
5 Segment by Application
5.1 Global Prilide Antihypertensive Drugs Sales by Application (2024-2034)
5.1.1 Global Prilide Antihypertensive Drugs Sales by Application (2024-2024)
5.1.2 Global Prilide Antihypertensive Drugs Sales by Application (2024-2034)
5.1.3 Global Prilide Antihypertensive Drugs Sales Market Share by Application (2024-2034)
5.2 Global Prilide Antihypertensive Drugs Revenue by Application (2024-2034)
5.2.1 Global Prilide Antihypertensive Drugs Revenue by Application (2024-2024)
5.2.2 Global Prilide Antihypertensive Drugs Revenue by Application (2024-2034)
5.2.3 Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2024-2034)
5.3 Global Prilide Antihypertensive Drugs Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Merck Prilide Antihypertensive Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Pfizer Prilide Antihypertensive Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Sanofi Prilide Antihypertensive Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Abbott Prilide Antihypertensive Drugs Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Novartis Prilide Antihypertensive Drugs Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Changzhou Pharmaceutical
6.6.1 Changzhou Pharmaceutical Corporation Information
6.6.2 Changzhou Pharmaceutical Description and Business Overview
6.6.3 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.6.5 Changzhou Pharmaceutical Recent Developments/Updates
6.7 Humanwell Pharmaceutical
6.6.1 Humanwell Pharmaceutical Corporation Information
6.6.2 Humanwell Pharmaceutical Description and Business Overview
6.6.3 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.7.5 Humanwell Pharmaceutical Recent Developments/Updates
6.8 Hengcheng Pharmaceutical
6.8.1 Hengcheng Pharmaceutical Corporation Information
6.8.2 Hengcheng Pharmaceutical Description and Business Overview
6.8.3 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.8.5 Hengcheng Pharmaceutical Recent Developments/Updates
6.9 Hengwei Pharmaceutical
6.9.1 Hengwei Pharmaceutical Corporation Information
6.9.2 Hengwei Pharmaceutical Description and Business Overview
6.9.3 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.9.5 Hengwei Pharmaceutical Recent Developments/Updates
6.10 Zhongfu Pharmaceutical
6.10.1 Zhongfu Pharmaceutical Corporation Information
6.10.2 Zhongfu Pharmaceutical Description and Business Overview
6.10.3 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.10.5 Zhongfu Pharmaceutical Recent Developments/Updates
6.11 Likang Pharmaceutical
6.11.1 Likang Pharmaceutical Corporation Information
6.11.2 Likang Pharmaceutical Prilide Antihypertensive Drugs Description and Business Overview
6.11.3 Likang Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Likang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.11.5 Likang Pharmaceutical Recent Developments/Updates
6.12 Changjiang Pharmaceutical
6.12.1 Changjiang Pharmaceutical Corporation Information
6.12.2 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Description and Business Overview
6.12.3 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.12.5 Changjiang Pharmaceutical Recent Developments/Updates
6.13 Baiyunshan Pharmaceutical
6.13.1 Baiyunshan Pharmaceutical Corporation Information
6.13.2 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Description and Business Overview
6.13.3 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.13.5 Baiyunshan Pharmaceutical Recent Developments/Updates
6.14 Poly Pharm
6.14.1 Poly Pharm Corporation Information
6.14.2 Poly Pharm Prilide Antihypertensive Drugs Description and Business Overview
6.14.3 Poly Pharm Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Poly Pharm Prilide Antihypertensive Drugs Product Portfolio
6.14.5 Poly Pharm Recent Developments/Updates
6.15 Lukang Group
6.15.1 Lukang Group Corporation Information
6.15.2 Lukang Group Prilide Antihypertensive Drugs Description and Business Overview
6.15.3 Lukang Group Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Lukang Group Prilide Antihypertensive Drugs Product Portfolio
6.15.5 Lukang Group Recent Developments/Updates
6.16 Baili Pharmaceutical
6.16.1 Baili Pharmaceutical Corporation Information
6.16.2 Baili Pharmaceutical Prilide Antihypertensive Drugs Description and Business Overview
6.16.3 Baili Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Baili Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.16.5 Baili Pharmaceutical Recent Developments/Updates
6.17 Huahai Pharmaceutical
6.17.1 Huahai Pharmaceutical Corporation Information
6.17.2 Huahai Pharmaceutical Prilide Antihypertensive Drugs Description and Business Overview
6.17.3 Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Huahai Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.17.5 Huahai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prilide Antihypertensive Drugs Industry Chain Analysis
7.2 Prilide Antihypertensive Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prilide Antihypertensive Drugs Production Mode & Process
7.4 Prilide Antihypertensive Drugs Sales and Marketing
7.4.1 Prilide Antihypertensive Drugs Sales Channels
7.4.2 Prilide Antihypertensive Drugs Distributors
7.5 Prilide Antihypertensive Drugs Customers
8 Prilide Antihypertensive Drugs Market Dynamics
8.1 Prilide Antihypertensive Drugs Industry Trends
8.2 Prilide Antihypertensive Drugs Market Drivers
8.3 Prilide Antihypertensive Drugs Market Challenges
8.4 Prilide Antihypertensive Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Prilide Antihypertensive Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Prilide Antihypertensive Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Prilide Antihypertensive Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Prilide Antihypertensive Drugs Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Prilide Antihypertensive Drugs Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Prilide Antihypertensive Drugs Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Prilide Antihypertensive Drugs Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Prilide Antihypertensive Drugs Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Prilide Antihypertensive Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Prilide Antihypertensive Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prilide Antihypertensive Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Prilide Antihypertensive Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prilide Antihypertensive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prilide Antihypertensive Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prilide Antihypertensive Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Prilide Antihypertensive Drugs Sales by Region (2024-2024) & (K Units)
Table 18. Global Prilide Antihypertensive Drugs Sales Market Share by Region (2024-2024)
Table 19. Global Prilide Antihypertensive Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Prilide Antihypertensive Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Prilide Antihypertensive Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2024-2024)
Table 23. Global Prilide Antihypertensive Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Prilide Antihypertensive Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Prilide Antihypertensive Drugs Sales by Country (2024-2024) & (K Units)
Table 27. North America Prilide Antihypertensive Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Prilide Antihypertensive Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Prilide Antihypertensive Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Prilide Antihypertensive Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Prilide Antihypertensive Drugs Sales by Country (2024-2024) & (K Units)
Table 32. Europe Prilide Antihypertensive Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Prilide Antihypertensive Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Prilide Antihypertensive Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Prilide Antihypertensive Drugs Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Prilide Antihypertensive Drugs Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Prilide Antihypertensive Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Prilide Antihypertensive Drugs Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Prilide Antihypertensive Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Prilide Antihypertensive Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Prilide Antihypertensive Drugs Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Prilide Antihypertensive Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Prilide Antihypertensive Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Prilide Antihypertensive Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Prilide Antihypertensive Drugs Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Prilide Antihypertensive Drugs Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Prilide Antihypertensive Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Prilide Antihypertensive Drugs Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Prilide Antihypertensive Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Prilide Antihypertensive Drugs Sales (K Units) by Type (2024-2024)
Table 51. Global Prilide Antihypertensive Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2024-2024)
Table 53. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Prilide Antihypertensive Drugs Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Prilide Antihypertensive Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2024-2024)
Table 57. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Type (2024-2024)
Table 59. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Type (2024-2034)
Table 60. Global Prilide Antihypertensive Drugs Sales (K Units) by Application (2024-2024)
Table 61. Global Prilide Antihypertensive Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2024-2024)
Table 63. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Prilide Antihypertensive Drugs Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Prilide Antihypertensive Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2024-2024)
Table 67. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Application (2024-2024)
Table 69. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Merck Prilide Antihypertensive Drugs Product
Table 74. Merck Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Pfizer Prilide Antihypertensive Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Sanofi Prilide Antihypertensive Drugs Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Abbott Corporation Information
Table 86. Abbott Description and Business Overview
Table 87. Abbott Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Abbott Prilide Antihypertensive Drugs Product
Table 89. Abbott Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Novartis Prilide Antihypertensive Drugs Product
Table 94. Novartis Recent Developments/Updates
Table 95. Changzhou Pharmaceutical Corporation Information
Table 96. Changzhou Pharmaceutical Description and Business Overview
Table 97. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product
Table 99. Changzhou Pharmaceutical Recent Developments/Updates
Table 100. Humanwell Pharmaceutical Corporation Information
Table 101. Humanwell Pharmaceutical Description and Business Overview
Table 102. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product
Table 104. Humanwell Pharmaceutical Recent Developments/Updates
Table 105. Hengcheng Pharmaceutical Corporation Information
Table 106. Hengcheng Pharmaceutical Description and Business Overview
Table 107. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product
Table 109. Hengcheng Pharmaceutical Recent Developments/Updates
Table 110. Hengwei Pharmaceutical Corporation Information
Table 111. Hengwei Pharmaceutical Description and Business Overview
Table 112. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product
Table 114. Hengwei Pharmaceutical Recent Developments/Updates
Table 115. Zhongfu Pharmaceutical Corporation Information
Table 116. Zhongfu Pharmaceutical Description and Business Overview
Table 117. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product
Table 119. Zhongfu Pharmaceutical Recent Developments/Updates
Table 120. Likang Pharmaceutical Corporation Information
Table 121. Likang Pharmaceutical Description and Business Overview
Table 122. Likang Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Likang Pharmaceutical Prilide Antihypertensive Drugs Product
Table 124. Likang Pharmaceutical Recent Developments/Updates
Table 125. Changjiang Pharmaceutical Corporation Information
Table 126. Changjiang Pharmaceutical Description and Business Overview
Table 127. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product
Table 129. Changjiang Pharmaceutical Recent Developments/Updates
Table 130. Baiyunshan Pharmaceutical Corporation Information
Table 131. Baiyunshan Pharmaceutical Description and Business Overview
Table 132. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product
Table 134. Baiyunshan Pharmaceutical Recent Developments/Updates
Table 135. Poly Pharm Corporation Information
Table 136. Poly Pharm Description and Business Overview
Table 137. Poly Pharm Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Poly Pharm Prilide Antihypertensive Drugs Product
Table 139. Poly Pharm Recent Developments/Updates
Table 140. Lukang Group Corporation Information
Table 141. Lukang Group Description and Business Overview
Table 142. Lukang Group Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Lukang Group Prilide Antihypertensive Drugs Product
Table 144. Lukang Group Recent Developments/Updates
Table 145. Baili Pharmaceutical Corporation Information
Table 146. Baili Pharmaceutical Description and Business Overview
Table 147. Baili Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Baili Pharmaceutical Prilide Antihypertensive Drugs Product
Table 149. Baili Pharmaceutical Recent Developments/Updates
Table 150. Huahai Pharmaceutical Corporation Information
Table 151. Huahai Pharmaceutical Description and Business Overview
Table 152. Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Huahai Pharmaceutical Prilide Antihypertensive Drugs Product
Table 154. Huahai Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Prilide Antihypertensive Drugs Distributors List
Table 158. Prilide Antihypertensive Drugs Customers List
Table 159. Prilide Antihypertensive Drugs Market Trends
Table 160. Prilide Antihypertensive Drugs Market Drivers
Table 161. Prilide Antihypertensive Drugs Market Challenges
Table 162. Prilide Antihypertensive Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prilide Antihypertensive Drugs
Figure 2. Global Prilide Antihypertensive Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Prilide Antihypertensive Drugs Market Share by Type in 2022 & 2034
Figure 4. Captopril Product Picture
Figure 5. Enalapril Product Picture
Figure 6. Lisinopril Product Picture
Figure 7. Fosinopril Product Picture
Figure 8. Others Product Picture
Figure 9. Global Prilide Antihypertensive Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Prilide Antihypertensive Drugs Market Share by Application in 2022 & 2034
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Global Prilide Antihypertensive Drugs Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 14. Global Prilide Antihypertensive Drugs Market Size (2024-2034) & (US$ Million)
Figure 15. Global Prilide Antihypertensive Drugs Sales (2024-2034) & (K Units)
Figure 16. Global Prilide Antihypertensive Drugs Average Price (US$/Unit) & (2024-2034)
Figure 17. Prilide Antihypertensive Drugs Report Years Considered
Figure 18. Prilide Antihypertensive Drugs Sales Share by Manufacturers in 2022
Figure 19. Global Prilide Antihypertensive Drugs Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Prilide Antihypertensive Drugs Players: Market Share by Revenue in 2022
Figure 21. Prilide Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 22. Global Prilide Antihypertensive Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 23. North America Prilide Antihypertensive Drugs Sales Market Share by Country (2024-2034)
Figure 24. North America Prilide Antihypertensive Drugs Revenue Market Share by Country (2024-2034)
Figure 25. United States Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Canada Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Europe Prilide Antihypertensive Drugs Sales Market Share by Country (2024-2034)
Figure 28. Europe Prilide Antihypertensive Drugs Revenue Market Share by Country (2024-2034)
Figure 29. Germany Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. France Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. U.K. Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Italy Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Russia Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Asia Pacific Prilide Antihypertensive Drugs Sales Market Share by Region (2024-2034)
Figure 35. Asia Pacific Prilide Antihypertensive Drugs Revenue Market Share by Region (2024-2034)
Figure 36. China Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Japan Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. South Korea Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. India Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Australia Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. China Taiwan Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Southeast Asia Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Latin America Prilide Antihypertensive Drugs Sales Market Share by Country (2024-2034)
Figure 44. Latin America Prilide Antihypertensive Drugs Revenue Market Share by Country (2024-2034)
Figure 45. Mexico Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Brazil Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Argentina Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Middle East & Africa Prilide Antihypertensive Drugs Sales Market Share by Country (2024-2034)
Figure 49. Middle East & Africa Prilide Antihypertensive Drugs Revenue Market Share by Country (2024-2034)
Figure 50. Turkey Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Saudi Arabia Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. UAE Prilide Antihypertensive Drugs Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Prilide Antihypertensive Drugs by Type (2024-2034)
Figure 54. Global Revenue Market Share of Prilide Antihypertensive Drugs by Type (2024-2034)
Figure 55. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Type (2024-2034)
Figure 56. Global Sales Market Share of Prilide Antihypertensive Drugs by Application (2024-2034)
Figure 57. Global Revenue Market Share of Prilide Antihypertensive Drugs by Application (2024-2034)
Figure 58. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Application (2024-2034)
Figure 59. Prilide Antihypertensive Drugs Value Chain
Figure 60. Prilide Antihypertensive Drugs Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed